TB
Teresa Brophy Bair
Chief Legal Officer

Teresa Brophy Bair insider trades: Kura Oncology (KURA) stock sales

Chief Legal Officer, Kura Oncology Last trade Sep 28, 2026 19 Form 4 filings
$701K
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2022
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Teresa reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 28, 2026KURA↓ Sell$89K
Aug 19, 2026KURA↓ Sell$398K
May 18, 2026KURA↓ Sell$21K
Jan 27, 2026KURA↓ Sell$95K
Nov 14, 2025KURA↓ Sell$98K
Sep 29, 2025KURA↓ Sell$79K
May 19, 2025KURA↓ Sell$9K
Jan 28, 2025KURA↓ Sell$57K
May 20, 2024KURA↓ Sell$58K
Jan 29, 2024KURA↓ Sell$37K
Nov 17, 2022KURA↓ Sell$32K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other KURA insiders

Open-market trades in the last 12 months

About Teresa Brophy Bair's insider trades

Teresa Brophy Bair is Chief Legal Officer at Kura Oncology (KURA). Since Nov 17, 2022, Teresa has reported no open-market purchases and 11 sales worth $972K on SEC Form 4. In the last 12 months: 5 sales ($701K).

Their filings also include grants and awards (10 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KURA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.